Oxprenolol (oxprenolol): Reviews and patient testimonials
Medication indications
Oxprenolol 20 mg Tablets
Trasicor Tablets are indicated in adults for the treatment of:
Angina Pectoris: For long-term prophylactic use (if necessary nitrates should be employed for alleviating acute attacks).
Hypertension: As monotherapy or for use in combination with other antihypertensives, e.g. with a diuretic, peripheral vasodilator, calcium channel blocker or ACE inhibitor.
Disturbances of cardiac rhythm: Especially supraventricular tachycardia, atrial fibrillation and digitalis-induced arrhythmias, ventricular tachycardia.
Short-term relief of functional cardiovascular disorders due to adrenergic hyperactivity: Such as cardiac neurosis, hyperkinetic heart syndrome and anxiety induced cardiovascular disorders.
Oxprenolol 40 mg Tablets
Trasicor Tablets are indicated in adults for the treatment of:
Angina Pectoris: For long-term prophylactic use (if necessary nitrates should be employed for alleviating acute attacks).
Hypertension: As monotherapy or for use in combination with other antihypertensives, e.g. with a diuretic, peripheral vasodilator, calcium channel blocker or ACE inhibitor. Disturbances of cardiac rhythm: Especially supraventricular tachycardia, atrial fibrillation and digitalis-induced arrhythmias, ventricular tachycardia.
Short-term relief of functional cardiovascular disorders due to adrenergic hyperactivity: Such as cardiac neurosis, hyperkinetic heart syndrome and anxiety induced cardiovascular disorders.
Oxprenolol 80 mg Tablets
Trasicor Tablets are indicated in adults for the treatment of:
Angina Pectoris: For long-term prophylactic use (if necessary nitrates should be employed for alleviating acute attacks).
Hypertension: As monotherapy or for use in combination with other antihypertensives, e.g. with a diuretic, peripheral vasodilator, calcium channel blocker or ACE inhibitor.
Disturbances of cardiac rhythm: Especially supraventricular tachycardia, atrial fibrillation and digitalis-induced arrhythmias, ventricular tachycardia.
Short-term relief of functional cardiovascular disorders due to adrenergic hyperactivity: Such as cardiac neurosis, hyperkinetic heart syndrome and anxiety induced cardiovascular disorders.
Route of administration: Oral
Molecule: oxprenolol
Patients' opinions on Oxprenolol
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.